Research team proves how neurotransmitter may be key in controlling Alzheimer's toxicity

With nearly 50 million dementia patients worldwide, Alzheimers’s disease is the most common neurodegenerative disease. Its main symptom is the impairment of general cognitive abilities, including the ability to speak or to remember. The importance of finding a cure is widely understood with an increasingly aging population and life expectancy being ever-extended. However, even the cause of the grim disease is yet to be given a clear definition.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup